BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15998904)

  • 1. Targeting signal transduction pathways in colorectal cancer--more than skin deep.
    Cohen SJ; Cohen RB; Meropol NJ
    J Clin Oncol; 2005 Aug; 23(23):5374-85. PubMed ID: 15998904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary: targeting colorectal cancer through molecular biology.
    Kumar R
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S37-9. PubMed ID: 16399429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New strategies in colorectal cancer: biomarkers of response to epidermal growth factor receptor monoclonal antibodies and potential therapeutic targets in phosphoinositide 3-kinase and mitogen-activated protein kinase pathways.
    Dasari A; Messersmith WA
    Clin Cancer Res; 2010 Aug; 16(15):3811-8. PubMed ID: 20554751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma.
    Venook AP
    Cancer; 2005 Jun; 103(12):2435-46. PubMed ID: 15880563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the predictive role of K-ras for epidermal growth factor receptor-targeted therapies in colorectal cancer.
    Ramos FJ; Macarulla T; Capdevila J; Elez E; Tabernero J
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S52-7. PubMed ID: 19064407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long road to colorectal cancer therapy: searching for the right signals.
    Hollande F; Pannequin J; Joubert D
    Drug Resist Updat; 2010; 13(1-2):44-56. PubMed ID: 20176501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular markers in the treatment of metastatic colorectal cancer.
    Wilson PM; Labonte MJ; Lenz HJ
    Cancer J; 2010; 16(3):262-72. PubMed ID: 20526105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
    Faivre S; Djelloul S; Raymond E
    Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting growth factors and angiogenesis; using small molecules in malignancy.
    Wanebo HJ; Argiris A; Bergsland E; Agarwala S; Rugo H
    Cancer Metastasis Rev; 2006 Jun; 25(2):279-92. PubMed ID: 16770540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key cancer cell signal transduction pathways as therapeutic targets.
    Bianco R; Melisi D; Ciardiello F; Tortora G
    Eur J Cancer; 2006 Feb; 42(3):290-4. PubMed ID: 16376541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor tyrosine kinase inhibitors: present and future role in gastrointestinal cancer treatment: a review.
    Arnold D; Peinert S; Voigt W; Schmoll HJ
    Oncologist; 2006 Jun; 11(6):602-11. PubMed ID: 16794239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon regulatory factor-5-regulated pathways as a target for colorectal cancer therapeutics.
    Hu G; Barnes BJ
    Expert Rev Anticancer Ther; 2006 May; 6(5):775-84. PubMed ID: 16759167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in targeted therapies for colorectal cancer.
    Milano M; Guerin O
    J Oncol Pharm Pract; 2006 Jun; 12(2):69-73. PubMed ID: 16984744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms and targeting of colorectal cancer.
    Vanhoefer U
    Semin Oncol; 2005 Dec; 32(6 Suppl 8):7-10. PubMed ID: 16360005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular signal transduction pathway proteins as targets for cancer therapy.
    Adjei AA; Hidalgo M
    J Clin Oncol; 2005 Aug; 23(23):5386-403. PubMed ID: 15983388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel therapeutic developments other than EGFR and VEGF inhibition in colorectal cancer.
    Wilson RH
    Oncologist; 2006 Oct; 11(9):1018-24. PubMed ID: 17030644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic colorectal cancer.
    Saletti P; Cavalli F
    Cancer Treat Rev; 2006 Nov; 32(7):557-71. PubMed ID: 16935430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel targets for anticancer treatment development in colorectal cancer.
    Macarulla T; Ramos FJ; Capdevila J; Saura C; Tabernero J
    Clin Colorectal Cancer; 2006 Nov; 6(4):265-72. PubMed ID: 17241511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor pathway targeted therapy in patients with aerodigestive malignancies.
    Patel JD
    Curr Opin Oncol; 2006 Nov; 18(6):609-14. PubMed ID: 16988582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis and colorectal cancer: implications for therapy.
    Yang SY; Sales KM; Fuller B; Seifalian AM; Winslet MC
    Trends Mol Med; 2009 May; 15(5):225-33. PubMed ID: 19362056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.